甲氧基聚乙二醇双十四烷基乙酰胺
产品简称：ALC-0159（mPEG-DTA）CAS no.：1849616-42-7
| CAS no. | 分子量（Mp） | 产品编码 |
| 2,000 | 06020112302 | |
| 5,000 | 06020112306 | |
| 10,000 | 06020112309 | |
| 20,000 | 06020112312 | |
| 30,000 | 06020112313 | |
| 40,000 | 06020112315 |
该产品受到第三方专利的保护，本公司不供应该产品，仅：（a）提供与专利不冲突的一般性技术咨询；（b）在有第三方专利权人许可的前提下接受定制和CMO服务。如有需求可留言联系我司。
CDE登记号：F20210000384；DMF登记号：038112
查库存 / 立即抢购：因官网暂不支持直接下单，可点击链接跳转至商城选购，一键锁定现货
即刻跳转
mPEG-DTA | 甲氧基聚乙二醇双十四烷基乙酰胺
相关文献：
1. Nguyen CM, Vu TT, Nguyen MN, et al. Neoantigen-d mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model. Cancer Immunol Immunother. 2025;74(4):145. Published 2025 Mar 12. doi:10.1007/s00262-025-03992-7
2. Liu S, Wen Y, Shan X, et al. Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination. Nat Commun. 2024;15(1):9471. Published 2024 Nov 2. doi:10.1038/s41467-024-53914-x
3. Li M, Zheng X, Yu X, et al. Potentiating the Efficacy of mRNA Vaccines through NIR-II Imaging-Guided Precise Vaccination. Adv Sci (Weinh). 2025;12(37):e13014. doi:10.1002/advs.202413014
4. Kim S, Jeon JH, Kim M, et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site. Nat Commun. 2024;15(1):7226. Published 2024 Aug 27. doi:10.1038/s41467-024-51411-9
5. Liu D, Wang X, Xu L, et al. Screening lipid nanoparticles using DNA barcoding and qPCR. Colloids Surf B Biointerfaces. 2025;251:114598. doi:10.1016/j.colsurfb.2025.114598
6. Hassanel DNBP, Pilkington EH, Ju Y, Kent SJ, Pouton CW, Truong NP. Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024;665:124695. doi:10.1016/j.ijpharm.2024.124695
7. Tao Y, Tian C, Qi S, et al. Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors. Nat Cancer. 2025;6(4):702-717. doi:10.1038/s43018-025-00930-5
8. Yang K, Bai B, Li X, et al. Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy. Sci Adv. 2025;11(9):eadn7256. doi:10.1126/sciadv.adn7256
9. Wang Y, Luo G, Wang H, et al. Evaluating cell cycle- and autophagy-associated cellular accumulation of lipid-d nanoparticles. Nat Commun. 2025;16(1):5964. Published 2025 Jul 1. doi:10.1038/s41467-025-60962-4
10. Sui, Meihua & Wang, Yisha & Luo, Gan & Wang, Haiyang & Zheng, Yue & Zhou, Wenbin & Lin, Junrong & Chen, Baocheng. (2024). Construction and Application of a Technical Platform for Determining Cell Cycle- and Autophagy-Associated Cellular Uptake of Lipid-d Nanoparticles. 10.21203/rs.3.rs-3974581/v1.
11. Wang H, Wang Y, Yuan C, et al. Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats. NPJ Vaccines. 2023;8(1):169. Published 2023 Nov 2. doi:10.1038/s41541-023-00766-z
12. Men J, Zhang X, Zhang W, Gao X, Cheng M, Yu X, Qi S. Synergistic inhibition of exosome secretion and PD-L1 silence via a functional supramolecular lipid nanoparticle to boost antitumor immunity. J Control Release. 2026;399(Pt A):115331. doi:10.1016/j.jconrel.2026.115331
13. Zhou H, Sun Y, Zhang L, Liang X, Bai J, Gao Y, Jiang P. An mRNA vaccine encoding multiple envelope glycoproteins of porcine reproductive and respiratory syndrome virus confers efficient protection against NADC30-like strains. Int J Biol Macromol. 2026 Jan;339(Pt 2):149888. doi: 10.1016/j.ijbiomac.2025.149888. Epub 2025 Dec 23. PMID: 41448308.
14. Handa K, Kawamura M, Sasai M, Matsuzaki T, Harada A, Fujimura L, Whitehouse J, Saito S, Komukai S, Kitamura T, Fujishiro A, Hirano K, Miki K, Miyagawa S. Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart. J Control Release. 2025 May 10;381:113623. doi: 10.1016/j.jconrel.2025.113623. Epub 2025 Mar 10. PMID: 40073941.
15. Jiang L, Zhou W, Liu F, Li W, Xu Y, Liang Z, Cao M, Hou L, Liu P, Wu F, Shen A, Zhang Z, Zhang X, Zhao H, Pan X, Wu T, Jia W, Zhang Y. An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Naïve/Primed Murine Models. Vaccines (Basel). 2025 Mar 19;13(3):327. doi: 10.3390/vaccines13030327. PMID: 40266224; PMCID: PMC11946168.
16. Nguyen CM, Vu TT, Nguyen MN, Tran-Nguyen TS, Huynh CT, Ha QT, Nguyen HN, Tran LS. Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model. Cancer Immunol Immunother. 2025 Mar 12;74(4):145. doi: 10.1007/s00262-025-03992-7. PMID: 40072566; PMCID: PMC11949242.
17. Zhang J, Li Y, Zeng F, Mu C, Liu C, Wang L, Peng X, He L, Su Y, Li H, Wang A, Feng L, Gao D, Zhang Z, Xu G, Wang Y, Yue R, Si J, Zheng L, Zhang X, He F, Yi H, Tang Z, Li G, Ma K, Li Q. Virus-like structures for combination antigen protein mRNA vaccination. Nat Nanotechnol. 2024 Aug;19(8):1224-1233. doi: 10.1038/s41565-024-01679-1. Epub 2024 May 27. PMID: 38802667; PMCID: PMC11329372.
关键词:Methoxypoly(ethylene glycol)-ditetradecylacetamidemPEG-DTA2-[(polyethylene glycol)-2000]-NN-ditetradecylacetamidePrizer、Moderna新冠疫苗辅料厦门赛诺邦格致力于药物释放系统工作，为全球的制药和医疗器械公司提供产品、技术与服务。我们的工厂通过了ISO9001和ISO13485认证，并按照ICH-Q7A（FDA原料药GMP指南）组织生产产品。
我们的网站可能没有完全列出所有产品，更多产品请致电：0592-7761068
我们同时向所有客户提供定制合成的服务，也可邮箱联系：sales@sinopeg.com
